• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇诱导子宫内膜癌细胞耐药的生物学特性及机制研究。

Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells.

机构信息

The Third Affiliated Hospital, Sun Yat-sen University, Guangdong Province, China.

The Seventh Affiliated Hospital, Sun Yat-sen University, Guangdong Province, China.

出版信息

Biomed Res Int. 2018 Aug 5;2018:8372085. doi: 10.1155/2018/8372085. eCollection 2018.

DOI:10.1155/2018/8372085
PMID:30175145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6098927/
Abstract

OBJECTIVE

To study the biological characteristics of paclitaxel resistant endometrial carcinoma cells and its mechanism of drug resistance.

METHOD

The paclitaxel resistant cell lines were established by high-dose paclitaxel (TAX) injection. The IC50 of paclitaxel was determined by CCK-8 assay in Ishikawa and Ishikawa-TAX. The cell cycle and apoptosis rate were detected by flow cytometry. Western blot was used to detect the expression of p-AKT and p-p70S6K. The expression of drug resistance-related genes Pgp and MDR1 was determined by RT-PCR. Cell viability was determined by soft agarose assay and invasive ability in vitro by transwell assay.

RESULTS

Paclitaxel and NVP-BEZ235 cotreatment group can further inhibit the clonogenicity and invasion of Ishikawa and Ishikawa-TAX cells compared with paclitaxel alone and NVP-BEZ235 treatment group. Paclitaxel and NVP-BEZ235 cotreated groups increased the apoptosis rate of Ishikawa and increased G0/G1 phase arrest in both cells. Paclitaxel alone significantly inhibited p-AK and p-p70 S6K protein expression in Ishikawa and Ishikawa-TAX cells and the inhibition was enhanced by NVP-BEZ235 when cotreated with paclitaxel.

CONCLUSION

Paclitaxel can inhibit Ishikawa and Ishikawa-TAX cell via PI3K/Akt/mTOR signaling pathway. Paclitaxel and NVP-BEZ235 cotreatment can enhance the inhibitory effect.

摘要

目的

研究紫杉醇耐药型子宫内膜癌细胞的生物学特性及其耐药机制。

方法

采用高剂量紫杉醇(TAX)注射法建立紫杉醇耐药细胞系。用 CCK-8 法检测 Ishikawa 和 Ishikawa-TAX 细胞中紫杉醇的 IC50。用流式细胞术检测细胞周期和凋亡率。用 Western blot 检测 p-AKT 和 p-p70S6K 的表达。用 RT-PCR 检测耐药相关基因 Pgp 和 MDR1 的表达。用软琼脂克隆形成实验检测细胞活力,用 Transwell 体外侵袭实验检测细胞的侵袭能力。

结果

紫杉醇与 NVP-BEZ235 联合处理组比紫杉醇单药和 NVP-BEZ235 处理组能进一步抑制 Ishikawa 和 Ishikawa-TAX 细胞的集落形成和侵袭能力。紫杉醇与 NVP-BEZ235 联合处理组增加了 Ishikawa 细胞的凋亡率,并使两种细胞均发生 G0/G1 期阻滞。紫杉醇单药处理明显抑制了 Ishikawa 和 Ishikawa-TAX 细胞中 p-AKT 和 p-p70 S6K 蛋白的表达,而与 NVP-BEZ235 联合处理时增强了抑制作用。

结论

紫杉醇可通过 PI3K/Akt/mTOR 信号通路抑制 Ishikawa 和 Ishikawa-TAX 细胞。紫杉醇与 NVP-BEZ235 联合处理可增强抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/c08db55309bb/BMRI2018-8372085.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/2f9701cec06c/BMRI2018-8372085.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/d755136bfc81/BMRI2018-8372085.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/1f55438e2197/BMRI2018-8372085.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/671e31a3df23/BMRI2018-8372085.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/f3f29063356e/BMRI2018-8372085.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/5299e5f381cf/BMRI2018-8372085.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/56bdacafa42d/BMRI2018-8372085.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/70890ee57e09/BMRI2018-8372085.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/c08db55309bb/BMRI2018-8372085.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/2f9701cec06c/BMRI2018-8372085.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/d755136bfc81/BMRI2018-8372085.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/1f55438e2197/BMRI2018-8372085.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/671e31a3df23/BMRI2018-8372085.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/f3f29063356e/BMRI2018-8372085.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/5299e5f381cf/BMRI2018-8372085.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/56bdacafa42d/BMRI2018-8372085.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/70890ee57e09/BMRI2018-8372085.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b01/6098927/c08db55309bb/BMRI2018-8372085.009.jpg

相似文献

1
Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells.紫杉醇诱导子宫内膜癌细胞耐药的生物学特性及机制研究。
Biomed Res Int. 2018 Aug 5;2018:8372085. doi: 10.1155/2018/8372085. eCollection 2018.
2
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.双重PI3K和mTOR抑制剂NVP-BEZ235联合甲磺酸伊马替尼对慢性粒细胞白血病细胞系的疗效。
Drug Des Devel Ther. 2017 Apr 3;11:1115-1126. doi: 10.2147/DDDT.S132092. eCollection 2017.
3
Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.对PI3K/AKT/mTOR(NVP-BEZ235)和Ras/Raf/MEK(AZD6244)通路的双重阻断可协同抑制原发性子宫内膜样子宫内膜癌培养物的生长,而NVP-BEZ235可减少相应异种移植模型中的肿瘤生长。
Gynecol Oncol. 2015 Jul;138(1):165-73. doi: 10.1016/j.ygyno.2015.04.028. Epub 2015 Apr 28.
4
NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.NVP-BEZ235,一种新型的双重 PI3K-mTOR 抑制剂,在人神经胶质瘤细胞中显示出抗神经胶质瘤活性,并降低替莫唑胺的化疗耐药性。
Cancer Lett. 2015 Oct 10;367(1):58-68. doi: 10.1016/j.canlet.2015.07.007. Epub 2015 Jul 15.
5
Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.依赖基因型的双重 PI3K/mTOR 抑制剂 NVP-BEZ235 和 mTOR 抑制剂 RAD001 在子宫内膜癌中的疗效。
PLoS One. 2012;7(5):e37431. doi: 10.1371/journal.pone.0037431. Epub 2012 May 25.
6
Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.紫杉醇与信号抑制剂联合作用于子宫内膜癌细胞的效果。
Asian Pac J Cancer Prev. 2011;12(11):2951-7.
7
Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells.比较 PI3K/mTOR 抑制剂 NVP-BEZ235 和 GSK2126458 对他莫昔芬耐药乳腺癌细胞的作用。
Cancer Biol Ther. 2011 Jun 1;11(11):938-46. doi: 10.4161/cbt.11.11.15527.
8
The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer.双重 PI3K/mTOR 抑制剂 NVP-BEZ235 增强实验性胃癌中 nab-紫杉醇的抗肿瘤反应。
Int J Oncol. 2013 Nov;43(5):1627-35. doi: 10.3892/ijo.2013.2099. Epub 2013 Sep 13.
9
[Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt Lymphoma RAJI Cell Line].[NVP-BEZ235对伯基特淋巴瘤RAJI细胞系阿霉素耐药的逆转作用]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):476-482. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.024.
10
Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia.新型双重 PI3K-MTORC1/2 抑制剂 NVP-BGT226 在急性白血病中的细胞周期依赖性活性。
Mol Cancer. 2013 May 24;12:46. doi: 10.1186/1476-4598-12-46.

引用本文的文献

1
knockout promotes paclitaxel sensitivity in drug-resistant cells induction of necrotic cell death.敲除可促进耐药细胞对紫杉醇的敏感性 诱导坏死性细胞死亡。
Korean J Physiol Pharmacol. 2020 May 1;24(3):233-240. doi: 10.4196/kjpp.2020.24.3.233.
2
Herb-Drug Interaction Potential of Licorice Extract and Paclitaxel: A Pharmacokinetic Study in Rats.甘草提取物与紫杉醇的药草-药物相互作用潜力:大鼠体内药代动力学研究
Eur J Drug Metab Pharmacokinet. 2020 Apr;45(2):257-264. doi: 10.1007/s13318-019-00593-5.
3
miR-522 facilitates the prosperities of endometrial carcinoma cells by directly binding to monoamine oxidase B.

本文引用的文献

1
MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells.微小RNA-128通过抑制癌症干细胞中的MUC1-C和BMI-1来抑制耐紫杉醇肺癌。
Oncotarget. 2017 Nov 30;8(66):110540-110551. doi: 10.18632/oncotarget.22818. eCollection 2017 Dec 15.
2
Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.子宫内膜间质肉瘤及相关肿瘤:新进展与诊断要点。
Pathology. 2018 Feb;50(2):162-177. doi: 10.1016/j.pathol.2017.11.086. Epub 2017 Dec 22.
3
Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins.
miR-522 通过直接结合单胺氧化酶 B 促进子宫内膜癌细胞的增殖。
Kaohsiung J Med Sci. 2019 Oct;35(10):598-606. doi: 10.1002/kjm2.12107. Epub 2019 Jul 4.
Rsf-1通过调节NF-κB信号通路及其下游蛋白影响非小细胞肺癌对紫杉醇的敏感性。
Cell Physiol Biochem. 2017;44(6):2322-2336. doi: 10.1159/000486116. Epub 2017 Dec 15.
4
Rolipram, a Selective Phosphodiesterase 4 Inhibitor, Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain through Inhibition of Inflammatory Cytokines in the Dorsal Root Ganglion.咯利普兰,一种选择性磷酸二酯酶4抑制剂,通过抑制背根神经节中的炎性细胞因子,改善化疗诱导的神经性疼痛大鼠模型中的机械性痛觉过敏。
Front Pharmacol. 2017 Dec 4;8:885. doi: 10.3389/fphar.2017.00885. eCollection 2017.
5
Endometriosis-associated malignant transformation in abdominal surgical scar: A PRISMA-compliant systematic review.腹部手术瘢痕中子宫内膜异位症相关的恶性转化:一项遵循PRISMA标准的系统评价
Medicine (Baltimore). 2017 Dec;96(49):e9136. doi: 10.1097/MD.0000000000009136.
6
New therapies for advanced, recurrent, and metastatic endometrial cancers.晚期、复发性和转移性子宫内膜癌的新疗法。
Gynecol Oncol Res Pract. 2017 Dec 2;4:19. doi: 10.1186/s40661-017-0056-7. eCollection 2017.
7
Endoplasmic Reticulum Stress Promotes Autophagy and Apoptosis and Reduces Chemotherapy Resistance in Mutant p53 Lung Cancer Cells.内质网应激促进突变型p53肺癌细胞的自噬和凋亡并降低化疗耐药性。
Cell Physiol Biochem. 2017;44(1):133-151. doi: 10.1159/000484622. Epub 2017 Nov 6.
8
MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.miR-129 通过靶向 ETS1 抑制前列腺癌细胞增殖和转移及其对 PI3K/AKT/mTOR 通路的调控
Biomed Pharmacother. 2017 Dec;96:634-641. doi: 10.1016/j.biopha.2017.10.037. Epub 2017 Nov 6.
9
Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.基于纳米白蛋白结合型紫杉醇的二线化疗对转移性胰腺癌的影响。
Anticancer Res. 2017 Oct;37(10):5533-5539. doi: 10.21873/anticanres.11985.
10
Increasing the affinity of cationized polyacrylamide-paclitaxel nanoparticles towards colon cancer cells by a surface recognition peptide.通过表面识别肽提高阳离子化聚丙烯酰胺-紫杉醇纳米颗粒对结肠癌细胞的亲和力。
Int J Pharm. 2017 Oct 5;531(1):281-291. doi: 10.1016/j.ijpharm.2017.08.092. Epub 2017 Aug 24.